Bruhn H D, Zurborn K H
I. Medizinische Universitätsklinik Kiel.
Dtsch Med Wochenschr. 1993 Jul 2;118(26):967-70. doi: 10.1055/s-2008-1059413.
It was the aim of this study to ascertain whether the plasma level of prothrombin fragment F1+2 is a suitable indicator of the anticoagulant effect of coumarin derivatives. The F1+2 levels were measured in 164 patients (100 women, 64 men; mean age 63.3 [34-83] years) in whom stable anticoagulation had been achieved with phenprocoumon, comparing the results with those obtained in healthy subjects (28 women, 19 men; mean age 54.6 [25-72] years) without anticoagulation. There was a significant reduction (P < 0.0005) in F1+2 plasma levels with oral anticoagulation (0.45 + 0.23 vs. 0.67 + 0.32 nmol/l). Even on a low degree of anticoagulation (international normalized ratio [INR] < 2.0) the F1+2 value was reduced to within the normal range (0.32-1.2 nmol/l). These results indicate that changes in the plasma level of prothrombin fragment F1+2 are directly dependent on the degree of oral anticoagulation and that this measure seems suitable for the monitoring of the anticoagulant effect. This is also true for oral anticoagulation of mild degree (INR < 2.0) in which the effect cannot be satisfactorily measured by the thromboplastin time (Quick test).
本研究的目的是确定凝血酶原片段F1+2的血浆水平是否是香豆素衍生物抗凝效果的合适指标。对164例已用苯丙香豆素实现稳定抗凝的患者(100名女性,64名男性;平均年龄63.3[34 - 83]岁)测定F1+2水平,并将结果与未接受抗凝的健康受试者(28名女性,19名男性;平均年龄54.6[25 - 72]岁)的结果进行比较。口服抗凝治疗后,F1+2血浆水平显著降低(P < 0.0005)(0.45 + 0.23对0.67 + 0.32 nmol/L)。即使在低抗凝程度(国际标准化比值[INR]<2.0)下,F1+2值也降至正常范围内(0.32 - 1.2 nmol/L)。这些结果表明,凝血酶原片段F1+2的血浆水平变化直接取决于口服抗凝的程度,并且该指标似乎适用于监测抗凝效果。对于轻度口服抗凝(INR<2.0)也是如此,在这种情况下,无法通过凝血活酶时间(Quick试验)令人满意地测定其效果。